Synthesis Of Levamisole Derivatives For Anti Cancer Activity
| dc.contributor.guide | Subhas S.Karki | |
| dc.coverage.spatial | ||
| dc.creator.researcher | Chudamani B | |
| dc.date.accessioned | 2022-12-21T11:25:04Z | |
| dc.date.available | 2022-12-21T11:25:04Z | |
| dc.date.awarded | 2022 | |
| dc.date.completed | 2022 | |
| dc.date.registered | ||
| dc.description.abstract | Cancer is responsible for millions of death every year. The drugs used to treat cancer bear severe side-effects. Hence, there is always a need for effective and safer molecules against it. It can be achieved either by screening the NCE or repurposing the existing one. The bioisosteric replacement on a synthetically versatile scaffold often gives the molecule with desired biological properties. In-silico analysis of existing drugs is also in use to find new anticancer moiety. Cell line based study, heterocyclic synthesis and CADD play vital role inthe process. newlineObjectives: newlineObjectives of the work is to design, synthesize and screen 2,6-substituted-imidazo[2,1-b] [1,3,4]thiadiazoles as levamisole derivativewith desired cytotoxic property and convert them to a potential lead against cancer newline | |
| dc.description.note | ||
| dc.format.accompanyingmaterial | None | |
| dc.format.dimensions | ||
| dc.format.extent | ||
| dc.identifier.uri | http://hdl.handle.net/10603/429581 | |
| dc.language | English | |
| dc.publisher.institution | Faculty of Pharmacy | |
| dc.publisher.place | Belgaum | |
| dc.publisher.university | KLE University | |
| dc.relation | ||
| dc.rights | university | |
| dc.source.university | University | |
| dc.subject.keyword | 2-Aralkyl-6-aryl-imidazo[2,1-b][1,3,4]thiadiazole;Cytotoxicity;Apoptosis; Caspase-3; DNA fragmentation;Levamisole;Melplhalan | |
| dc.subject.keyword | Clinical Pre Clinical and Health | |
| dc.subject.keyword | Pharmacology and Toxicology | |
| dc.title | Synthesis Of Levamisole Derivatives For Anti Cancer Activity | |
| dc.title.alternative | ||
| dc.type.degree | Ph.D. |